
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 130.00 |
| High | 135.00 |
| Low | 130.00 |
| Prev Close | 127.84 |
| Volume | 16,86,744 |
| VWAP(₹) | 133.04 |
| PE Ratio(x) | 28.63 |
| EPS - TTM(₹) | 4.69 |
| MCap(₹ Cr.) | 3,940.31 |
| MCap Rank | 65 |
| PB Ratio(x) | 2.11 |
| Div Yield(%) | 0.74 |
| Face Value(₹) | 2.00 |
| 52W High(₹) | 139.99 |
| 52W Low(₹) | 67.19 |
| MCap/Sales | 0.92 |
| Beta(1 Month) | 2.17 |
| BV/Share(₹) | 61.27 |
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 6.08%, which is highest in the last 3 years. (Source: Consolidated Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.36% outperformed its 3 year CAGR of 1.42%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 10.71% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)IOL Chemicals Share Price Update
IOL Chemicals and Pharmaceuticals Ltd. share price moved up by 5.01% from its previous close of Rs 127.84. IOL Chemicals and Pharmaceuticals Ltd. stock last traded price is 134.24
| Share Price | Value |
|---|---|
| Today/Current/Last | 134.24 |
| Previous Day | 127.84 |
Found Insights useful?
| 1 Day | 5.01% |
| 1 Month | 26.99% |
| 3 Months | 90.06% |
| 1 Year | 48.86% |
| 3 Years | 45.14% |
| 5 Years | 1.73% |
1 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 |
| Buy | - | - | - | - |
| Hold | - | - | - | - |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 1 | 1 | 1 | 2 |
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 621.29 | 585.68 | 574.41 | 559.06 | 532.31 |
| Total Income Growth (%) | 6.08 | 1.96 | 2.75 | 5.03 | 0.94 |
| Total Expenses | 547.27 | 554.50 | 530.44 | 509.32 | 483.58 |
| Total Expenses Growth (%) | -1.30 | 4.54 | 4.15 | 5.32 | -2.33 |
| EBIT | 74.02 | 31.18 | 43.97 | 49.74 | 48.73 |
| EBIT Growth (%) | 137.40 | -29.09 | -11.60 | 2.07 | 51.05 |
| Profit after Tax (PAT) | 53.16 | 20.58 | 29.97 | 33.93 | 31.42 |
| PAT Growth (%) | 158.31 | -31.33 | -11.67 | 7.99 | 53.04 |
| EBIT Margin (%) | 11.91 | 5.32 | 7.65 | 8.90 | 9.15 |
| Net Profit Margin (%) | 8.56 | 3.51 | 5.22 | 6.07 | 5.90 |
| Basic EPS (₹) | 1.81 | 0.70 | 1.02 | 1.16 | 1.07 |
All figures in Rs Cr, unless mentioned otherwise
Quarterly Topline Performance
Company witnessed QoQ revenue growth of 6.08%, which is highest in the last 3 years. (Source: Consolidated Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 11.36% outperformed its 3 year CAGR of 1.42%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | 2,586.95 | 2,382.07 | 2,244.40 | 2,022.13 |
| Total Assets Growth (%) | 8.60 | 6.13 | 10.99 | 3.05 |
| Total Liabilities | 788.40 | 694.41 | 632.89 | 514.41 |
| Total Liabilities Growth (%) | 13.54 | 9.72 | 23.03 | -9.76 |
| Total Equity | 1,798.55 | 1,687.66 | 1,611.51 | 1,507.72 |
| Total Equity Growth (%) | 6.57 | 4.73 | 6.88 | 8.29 |
| Current Ratio (x) | 1.78 | 1.89 | 2.00 | 2.02 |
| Total Debt to Equity (x) | 0.07 | 0.07 | 0.00 | 0.05 |
| Contingent Liabilities | 0.00 | 35.63 | 87.59 | 66.38 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Net Cash flow from Operating Activities | 214.32 | 178.62 | 290.08 | 122.27 |
| Net Cash used in Investing Activities | -198.11 | -154.18 | -191.28 | -120.00 |
| Net Cash flow from Financing Activities | -29.03 | 46.04 | -92.50 | -4.11 |
| Net Cash Flow | -12.82 | 70.48 | 6.30 | -1.84 |
| Closing Cash & Cash Equivalent | 65.35 | 78.17 | 7.69 | 1.39 |
| Closing Cash & Cash Equivalent Growth (%) | -16.40 | 916.51 | 453.24 | -60.96 |
| Total Debt/ CFO (x) | 0.62 | 0.66 | 0.00 | 0.65 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 198.11 cr for investing activities which is an YoY increase of 28.49%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Return on Equity (%) | 7.65 | 5.98 | 8.34 | 9.22 |
| Return on Capital Employed (%) | 11.07 | 8.61 | 11.74 | 13.09 |
| Return on Assets (%) | 5.32 | 4.24 | 5.98 | 6.88 |
| Interest Coverage Ratio (x) | 19.96 | 15.22 | 16.19 | 15.26 |
| Asset Turnover Ratio (x) | 0.93 | 0.90 | 1.00 | 1.11 |
| Price to Earnings (x) | 15.53 | 17.79 | 15.80 | 11.95 |
| Price to Book (x) | 1.19 | 1.06 | 1.32 | 1.10 |
| EV/EBITDA (x) | 7.13 | 7.59 | 7.59 | 6.84 |
| EBITDA Margin (%) | 12.52 | 10.80 | 12.22 | 11.33 |
Found Financials useful?
No Data Available
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
MF Ownership as on 30 April 2026
0.04
Amount Invested (in Cr.)
0.08458922%
% of AUM
-3.69
% Change (MoM basis)
0.02
Amount Invested (in Cr.)
0.08%
% of AUM
5.85
% Change (MoM basis)
0.00
Amount Invested (in Cr.)
0.00599327%
% of AUM
3.85
% Change (MoM basis)
General Meeting
-
May 20, 2026
Board Meeting
Audited Results
May 13, 2026
Interim Dividend
50%
Feb 11, 2026
| Announced on | Meeting on |
| May 13, 2026 | May 20, 2026 |
| Audited Results | |
| Jan 23, 2026 | Feb 11, 2026 |
| Quarterly Results & Interim Dividend | |
| Nov 04, 2025 | Nov 11, 2025 |
| Quarterly Results | |
| Jul 28, 2025 | Aug 07, 2025 |
| Quarterly Results | |
| May 06, 2025 | May 16, 2025 |
| Audited Results | |
| Announced on | Ex-Date | Dividend% |
| Feb 11, 2026 | Feb 17, 2026 | 50% |
| Feb 12, 2025 | Feb 18, 2025 | 40% |
| Feb 06, 2024 | Feb 16, 2024 | 50% |
| Feb 07, 2023 | Feb 17, 2023 | 40% |
| Feb 04, 2022 | Feb 15, 2022 | 40% |
No Data Available
| Announced on | Ex-Date |
| Dec 27, 2024 | Mar 11, 2025 |
| Split: Old FV10.0| New FV:2.0 | |
| Announced on | Ex-Date |
| Aug 22, 2005 | - |
| Rights ratio: 2 share for every 5 held at a price of Rs 42.0 | |
| Announced on | Meeting on |
| May 20, 2026 | Sep 02, 2026 |
| - | |
| Jul 31, 2025 | Aug 22, 2025 |
| - | |
| Jan 01, 2025 | Feb 02, 2025 |
| - | |
| Nov 12, 2024 | Dec 14, 2024 |
| - | |
| May 14, 2024 | Aug 23, 2024 |
| Book closure from Aug 17, 2024 to Aug 23, 2024 | |
IOL Chemicals and Pharmaceuticals Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 3,940.31 Crore) operating in Pharmaceuticals sector.
Industry
Key Indices Listed On
BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500
Address
Village & Post Office Handiaya,Fatehgarh Channa Road,Barnala, Punjab - 148107
Rajender Mohan Malla
Chairman & Ind.DirectorVarinder Gupta
Managing DirectorVikas Gupta
Joint Managing DirectorAbhiraj Gupta
Executive DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.